抗抑郁药处方的知识差距和系统性挑战:来自约旦精神病学实践的见解
Bayan Abdulhaq1, Walid Sarhan2, Mohammed Saadeh3
1School for International Training, Brattleboro, VT 05302, USA.
Healthcare (Basel, Switzerland)
|November 27, 2025
概括
约旦的精神病医生在应用抗抑郁药指南方面存在差距,许多人不承认国家标准. 改善指导方针传播和专业发展对于在低收入和中等收入国家的最佳处方至关重要.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 全球健康 全球健康
背景情况:
- 抗抑郁药物对全球治疗抑郁症至关重要.
- 在低收入和中等收入国家 (LMICs) 中,适当的抗抑郁药物使用至关重要,因为心理健康患病率很高.
- 有限的数据存在于LMIC的精神病医生处方实践,使得约旦成为一个关键的案例研究.
研究的目的:
- 评估约旦精神病医生的知识,态度和抗抑郁药的处方做法.
- 确定阻碍约旦最佳抗抑郁药物处方的挑战.
主要方法:
- 一种混合方法的方法,结合了横截面调查 (n=108) 和半结构面试 (n=4).
- 根据现有工具改编的调查工具,根据国际准则进行了改进.
- 对定性数据进行主题分析,对定量数据进行描述/回归分析.
主要成果:
- 精神病医生在知识上存在差距,只有34.3%的人承认国家指导方针,37.4%的人认为国际指导方针不适用.
- 实验室监测代谢副作用的不一致应用和常规咨询内部医学.
- 对孕妇/哺乳期妇女的处方持谨慎态度;职业生涯早期的精神病医生表现出较低的参与度.
结论:
- 系统性,临床医生和患者障碍妨碍了最佳的抗抑郁药物处方,尽管评估了安全性和结果.
- 建议加强国家指南的传播,改善药物获取和持续的专业发展.
- 调查结果为改善约旦和其他LMIC的处方实践提供了洞察力.
相关概念视频
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776
Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235
Depressive Disorders: Etiology
419
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
419
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Psychosis: Goals of Pharmacotherapy
449
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
449


